Replies to post #141297 on Rivulet Media Inc (fka RIVU)

[Inoviorulez]

Pending animal data, and other data an IND should only take 30 days to review from the time it's submitted. Straight from FDA website:http://www.fda.gov/drugs/developmentapprovalprocess/howdrugsaredevelopedandapproved/approvalapplications/investigationalnewdrugindapplication/default.htm

"Once the IND is submitted, the sponsor must wait 30 calendar days before initiating any clinical trials. During this time, FDA has an opportunity to review the IND for safety to assure that research subjects will not be subjected to unreasonable risk."

This company has already had responses back from the FDA so many times so what is the problem? Even with New chemical entities (new drugs) not yet tested in animals or humans it doesn't take one year + to file an IND. I'm sorry but I don't like what I have seen that has transpired with this company, and I feel sorry for shareholders that keep getting stringed along. Also for anyone that hasn't done any DD , the CEO koos also runs another sub penny stock ENTB as well. Something here smells fishy IMO.